Brian M. Gilfix

2.8k total citations
59 papers, 2.1k citations indexed

About

Brian M. Gilfix is a scholar working on Molecular Biology, Rheumatology and Surgery. According to data from OpenAlex, Brian M. Gilfix has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 23 papers in Rheumatology and 11 papers in Surgery. Recurrent topics in Brian M. Gilfix's work include Folate and B Vitamins Research (22 papers), Metabolism and Genetic Disorders (10 papers) and RNA modifications and cancer (6 papers). Brian M. Gilfix is often cited by papers focused on Folate and B Vitamins Research (22 papers), Metabolism and Genetic Disorders (10 papers) and RNA modifications and cancer (6 papers). Brian M. Gilfix collaborates with scholars based in Canada, United States and France. Brian M. Gilfix's co-authors include David S. Rosenblatt, Joséphine Nalbantoglu, Judes Poirier, Philìppe Bertrand, Richard L. Eckert, David Blank, Sheldon Magder, Martin R. Farlow, Debomoy K. Lahiri and S. Hui and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Brian M. Gilfix

57 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian M. Gilfix Canada 24 638 506 480 401 229 59 2.1k
Barry I. Joffe South Africa 27 370 0.6× 908 1.8× 319 0.7× 439 1.1× 255 1.1× 97 2.7k
Jorge E. Toblli Argentina 36 679 1.1× 172 0.3× 437 0.9× 278 0.7× 80 0.3× 125 3.5k
Speranza Rubattu Italy 34 889 1.4× 213 0.4× 477 1.0× 298 0.7× 199 0.9× 123 3.7k
R R Williams United States 26 348 0.5× 161 0.3× 234 0.5× 543 1.4× 381 1.7× 62 2.2k
W Grzeszczak Poland 31 587 0.9× 138 0.3× 362 0.8× 429 1.1× 382 1.7× 298 3.2k
Turgay İşbir Türkiye 28 962 1.5× 304 0.6× 195 0.4× 367 0.9× 248 1.1× 192 2.7k
Seok Seon Kang South Korea 24 384 0.6× 2.2k 4.4× 291 0.6× 1.3k 3.3× 156 0.7× 35 3.7k
Thomas C. Wascher Austria 32 972 1.5× 198 0.4× 731 1.5× 383 1.0× 277 1.2× 112 3.0k
Daniele Versari Italy 32 691 1.1× 93 0.2× 763 1.6× 566 1.4× 102 0.4× 59 3.5k
Shunya Uchida Japan 33 1.1k 1.7× 289 0.6× 517 1.1× 535 1.3× 155 0.7× 140 3.2k

Countries citing papers authored by Brian M. Gilfix

Since Specialization
Citations

This map shows the geographic impact of Brian M. Gilfix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian M. Gilfix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian M. Gilfix more than expected).

Fields of papers citing papers by Brian M. Gilfix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian M. Gilfix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian M. Gilfix. The network helps show where Brian M. Gilfix may publish in the future.

Co-authorship network of co-authors of Brian M. Gilfix

This figure shows the co-authorship network connecting the top 25 collaborators of Brian M. Gilfix. A scholar is included among the top collaborators of Brian M. Gilfix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian M. Gilfix. Brian M. Gilfix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Álvarez, Fernando, et al.. (2025). Defining the clinical spectrum and genotype-phenotype correlations for CCDC115-CDG: A patient report and review of the literature. Molecular Genetics and Metabolism. 146(3). 109234–109234.
2.
Watkins, David, et al.. (2023). Growth requirement for methionine in human melanoma-derived cell lines with different levels of MMACHC expression and methylation. Molecular Genetics and Metabolism. 141(1). 108111–108111. 1 indexed citations
3.
Gilfix, Brian M., Juan Rivera, Nader Sadeghi, et al.. (2020). The Role of the ThyroSeq v3 Molecular Test in the Surgical Management of Thyroid Nodules in the Canadian Public Health Care Setting. Thyroid. 30(9). 1280–1287. 43 indexed citations
4.
Gupta, Swati, Somayyeh Fahiminiya, Tracy Wang, et al.. (2016). Somatic overgrowth associated with homozygous mutations in both MAN1B1 and SEC23A. Molecular Case Studies. 2(3). a000737–a000737. 16 indexed citations
5.
Gilfix, Brian M.. (2014). Utility of measuring serum or red blood cell folate in the era of folate fortification of flour. Clinical Biochemistry. 47(7-8). 533–538. 10 indexed citations
6.
7.
Kent, Jana, Qiuying Huang, David Watkins, et al.. (2012). High resolution melting analysis of the MMAA gene in patients with cblA and in those with undiagnosed methylmalonic aciduria. Molecular Genetics and Metabolism. 107(3). 363–367. 22 indexed citations
8.
Rousseau, François, Carmen Lindsay, Yves Labelle, et al.. (2010). Development and description of GETT: a Genetic testing Evidence Tracking Tool. Clinical Chemistry and Laboratory Medicine (CCLM). 48(10). 1397–1407. 11 indexed citations
9.
Parente, Fabienne, Nicholas Ah Mew, Jaak Jaeken, & Brian M. Gilfix. (2009). A new Capillary Zone Electrophoresis method for the screening of Congenital Disorders of Glycosylation (CDG). Clinica Chimica Acta. 411(1-2). 64–66. 32 indexed citations
10.
Yamani, Lama, Bernard F. Gibbs, Brian M. Gilfix, et al.. (2008). Transcobalamin in cultured fibroblasts from patients with inborn errors of vitamin B12 metabolism. Molecular Genetics and Metabolism. 95(1-2). 104–106. 3 indexed citations
11.
Christou, Nicolas V., et al.. (2002). Pilot Study Examining the Frequency of Several Gene Polymorphisms in a Morbidly Obese Population. Obesity Surgery. 12(6). 759–764. 23 indexed citations
12.
Routy, Jean‐Pierre, et al.. (2001). Plasmapheresis in the treatment of an acute pancreatitis due to protease inhibitor‐induced hypertriglyceridemia. Journal of Clinical Apheresis. 16(3). 157–159. 32 indexed citations
13.
Adjalla, Charles, Angela Hosack, Brian M. Gilfix, et al.. (1998). Seven novel mutations inmut methylmalonic aciduria. Human Mutation. 11(4). 270–274. 25 indexed citations
14.
Théroux, Pierre, et al.. (1997). 'True' fasting serum insulin level, insulin resistance syndrome and coronary artery disease. Coronary Artery Disease. 8(11). 683–688. 12 indexed citations
15.
Gilfix, Brian M., et al.. (1997). Absence of the A1252G Mutation in α1-Antichymotrypsin in a North American Population Suffering from Dementia. Journal of Cerebral Blood Flow & Metabolism. 17(2). 233–235. 1 indexed citations
16.
O’Neil, William M., et al.. (1997). N-acetylation among HIV-positive patients and patients with AIDS: When is fast, fast and slow, slow?*. Clinical Pharmacology & Therapeutics. 62(3). 261–271. 39 indexed citations
17.
Nguyen, Dao M., Brian M. Gilfix, David Blank, et al.. (1996). Impact of transfusion of mediastinal shed blood on serum levels of cardiac enzymes. The Annals of Thoracic Surgery. 62(1). 109–114. 7 indexed citations
18.
Bose, Santanu, Richard Komorowski, Shakuntla Seetharam, et al.. (1996). In Vitro and in Vivo Inactivation of Transcobalamin II Receptor by Its Antiserum. Journal of Biological Chemistry. 271(8). 4195–4200. 24 indexed citations
19.
Solymoss, B, et al.. (1994). The place of ferritin among risk factors associated with coronary artery disease. Coronary Artery Disease. 5(3). 231–236. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry I. Joffe Breakdown of academic impact, for papers by Jorge E. Toblli Breakdown of academic impact, for papers by Speranza Rubattu Breakdown of academic impact, for papers by R R Williams Breakdown of academic impact, for papers by W Grzeszczak Breakdown of academic impact, for papers by Turgay İşbir Breakdown of academic impact, for papers by Seok Seon Kang Breakdown of academic impact, for papers by Thomas C. Wascher Breakdown of academic impact, for papers by Daniele Versari Breakdown of academic impact, for papers by Shunya Uchida
Rankless by CCL
2026